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Abstract
Since genetic engineering of pigs can benefit both biomedicine and agriculture, selecting a suitable gene
promoter is critically important. The cytomegalovirus (CMV) promoter, which can robustly drive ubiquitous
transgene expression, is commonly used at present, yet recent reports suggest tissue-specific activity in the pig.
The objective of this study was to quantify ZsGreen1 protein (in lieu of CMV promoter activity) in tissues from
pigs harboring a CMV-ZsGreen1 transgene with a single integration site. Tissue samples (n=35) were collected
from neonatal hemizygous (n=3) and homozygous (n=3) piglets and ZsGreen1 abundance was determined via
immunoblotting. ZsGreen1 was detected in all tissues, except hypothalamus, kidney cortex and oviduct. The
expression patterns of homozygous and hemizygous piglets were similar (P>0.05). However, quantification
revealed that ZsGreen1 protein levels were tissue-specific. Within neural/endocrine tissues, ZsGreen1 abundance
was highest in the anterior pituitary gland, intermediate in the cerebellum and lowest in the cerebrum, spinal cord
and posterior pituitary (P<0.05). In the digestive system, ZsGreen1 was more abundant in the salivary gland than
esophagus, stomach, pancreas, duodenum, jejunum, ileum, spleen, colon, gallbladder and liver (P<0.05).
Interestingly, ZsGreen1 amounts also differed within an organ (i.e., the right ventricle had 3-fold higher levels
than the other heart chambers; P<0.05). These results provide useful information for the use of the CMV promoter
to drive transgene expression in the pig. Moreover, this swine model represents a novel resource of ZsGreen1labeled organs and a valuable tool to advance genome editing research.
Keywords: gene expression profiling, CMV promoter, ZsGreen1, biomedical model, genome editing

Introduction
The use of genetically engineered pig models has
grown dramatically in recent years[1]. Transgenic
swine are increasingly utilized as animal models for
human diseases since they are anatomically,

physiologically and phylogenetically more similar to
humans than rodents[1]. In addition to biomedical
applications, genetically engineered pigs are also
developed to better understand porcine physiology
and enhance the agricultural industry[2–4]. Towards this
end, our laboratory produced a line of swine harboring
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a vector that contained: 1) the human U6 promoter
fused to small hairpin RNA (shRNA) specific to the
porcine gonadotropin-releasing hormone II (GnRH-II)
receptor and 2) the human cytomegalovirus (CMV)
promoter fused to the cDNA encoding the fluorescent
protein, ZsGreen1[2]. Previously, we evaluated the
impact of GnRH-II receptor knockdown (70%
reduced testicular mRNA levels) on reproductive
characteristics of male pigs[2]. Herein, we focus on the
human CMV promoter and ZsGreen1 reporter aspects
of this unique swine strain.
ZsGreen1 (Clontech, USA) is derived from
Anthozoa reef coral (Zoanthus species)[5] and
modified to maximize expression, solubility and
prompt chromophore maturation[6]. It is both
structurally and functionally distinct from other
fluorescent proteins, like green fluorescent protein
(GFP). The coding sequence of ZsGreen1 is only 26%
homologous to GFP[5] and ZsGreen1 exists as a
tetramer, whereas GFP (derived from luminescent
jellyfish) is a monomer[6]. Functionally, ZsGreen1
displays extremely bright fluorescence[7–8]. In fact,
yeast cells expressing ZsGreen exhibit 8.6-fold
brighter fluorescence than those expressing enhanced
GFP (EGFP)[7]. In addition, ZsGreen1, exhibiting high
signal-to-noise ratio[7], is highly photo-stabile and
unaffected by paraformaldehyde fixation[8]. Despite
these advantages, no transgenic swine lines containing
a ZsGreen1 reporter have been produced.
The human CMV immediate early promoter,
discovered by Boshart and coworkers[9], has been
heavily utilized to drive recombinant gene expression
due to its constitutive and promiscuous nature[10]. The
CMV promoter, now the most commonly used and
most robust ubiquitous promoter[11], is utilized to drive
transgene expression in numerous vertebrate animal
models including sheep[12–13], fish[11], mice[14–15], rats[16],
chickens[17] and pigs[18–19]. Pigs harboring a construct
containing the CMV promoter fused to GFP express
the transgene in a wide range of organs, including
those derived from each of the 3 germ layers: skin
(ectoderm), pancreas (endoderm), and kidney
(mesoderm). Despite apparent universal transgene
expression[19], the CMV promoter is preferentially
active in exocrine compared to non-exocrine cells of
the pig[18]. The objective of this study was to quantify
ZsGreen1 protein levels (in lieu of CMV promoter
activity) in a wide range of porcine tissues.

Materials and methods

the care and use of animals established by the
University of Nebraska –Lincoln (UNL) Institutional
Animal Care and Use Committee. These experiments
utilized transgenic swine that expressed ZsGreen1
controlled by the human CMV immediate early
promoter and were generated as previously described[2].
Briefly, transgenic piglets were produced by microinjection of lentiviral particles into the perivitelline
space of 1-cell porcine embryos. Lentiviral particles
were made using the Lenti-X pLVX-shRNA2 vector
and the HTX Packaging Mix (Clontech). The vector
contains 2 ubiquitous promoters, CMV (driving
ZsGreen1 expression) and the human U6 promoter
(controlling the expression of a shRNA specific for
the GnRHR-II gene). The background strain was a
Large White × Landrace composite line (Nebraska
Index line) developed and maintained[20] at the UNL
Eastern Nebraska Research and Extension Center
swine unit (Mead, NE, USA). Animals from this
background strain were transported to the UNL
Animal Science Building (Lincoln, NE, USA) and
used to derive the CMV-ZsGreen1 transgenic line of
pigs. This genetically-engineered swine line has been
expanded, maintained and studied within the confines
of the UNL Animal Science Building. In hemizygous
animals, one copy of the CMV-ZsGreen1 transgene is
stably integrated on chromosome 14[2], and has
remained transcriptionally active throughout the
lifetime of the founder animal and in 10 subsequent
generations.
Adult animals were housed individually with ad
libitum access to water and fed approximately 2.5 kg
of feed daily. Hemizygous CMV-ZsGreen1 transgenic
sows were artificially inseminated with semen from
non-littermate hemizygous transgenic boars and
allowed to gestate to term. Following Mendelian
inheritance, these matings yielded hemizygous,
homozygous (2 copies of the transgene), and nontransgenic (control) littermates in the proportions
expected with a single integration site. After
farrowing, piglets remained with their dam to suckle
ad libitum.
At 1 day of age, 3 littermate female piglets (control,
hemizygous transgenic and homozygous transgenic)
were selected from each of the 3 different litters; each
litter was produced from a different dam and sire
mating to maximize genetic diversity. Initially,
transgene status was assessed via evaluation of
ZsGreen1 expression using an ultraviolet (UV) light
and a Roscolux #15 filter (deep straw; Rosco, USA).

Animals

Tissue collection

All animal procedures followed the guidelines for

Piglets were first sedated with a mixture of telazol
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(Zoetis, USA), atropine (VetOne, USA), rompun
(Bayer, USA) and ketamine (VetOne) (TARK; 0.2
mg/kg atropine, 0.8 mg/kg rompun, 3.1 mg/kg
ketamine and 0.8 mg/kg telazol) delivered intramuscularly in the neck (1 mL/18–23 kg of body weight).
Animals were then euthanized via intracardiac
injection with Euthasol (1 mL/4.53 kg of body weight;
Delmarva Laboratories, USA). Following euthanasia,
tissue samples (n=35) generally representing 5
anatomical regions (brain, thoracic, digestive, renal
and reproductive) were collected from each transgenic
piglet. Isolated tissues included: cerebrum, cerebellum,
spinal cord, anterior pituitary gland, posterior pituitary
gland, hypothalamus, thymus, lymph node, the four
chambers of the heart, lung, muscle, thyroid, salivary
gland, esophagus, stomach, duodenum, jejunum,
ileum, large intestine, gall bladder, spleen, pancreas,
liver, kidney (medulla and cortex), bladder, adrenal
gland (medulla and cortex), ovary, uterus, oviduct,
and skin. Skin samples from control littermate piglets
were collected to serve as a negative control for
ZsGreen1 immunoblotting. In addition, tail samples
were collected from all piglets for genotyping. All
samples were frozen and stored at −80 °C until
analysis.
DNA extraction
Genomic DNA was isolated from tail samples using
enzymatic digestion and phenol/chloroform extraction.
Briefly, a tail slice (approximately 1 mm) was
incubated overnight in a lysing solution (50 mmol/L
Tris [pH 8.0], 150 mmol/L NaCl, 10 mmol/L EDTA,
1% sodium dodecyl sulfate [SDS], 0.1 mg/mL
Proteinase K [Fisher Bioreagents, USA], and 1% βmercaptoethanol) at 55 °C. The samples were extracted
twice with phenol: chloroform: isoamyl alcohol (25:
24:1) solution and once with chloroform: isoamyl
alcohol (24:1) solution before precipitating the DNA
with isopropanol. DNA was subsequently resuspended
in nuclease-free water.
Genotyping
Since we previously identified a single transgene
integration site on chromosome 14 (aligning with
clone NW_003612067.1 with 99% identity and
matching identities 448 946–448 372) via sequencing
analysis of inverse PCR products for this model[2],
copy number was evaluated via conventional PCR
using 3 primers. The forward (F) and reverse (R)
primers were designed to flank the insertion site of the
transgene, and an additional reverse primer aligning
the transgene (RT) was included (F: 5 ′-GCAAC
CTCTTCGACACTCCA-3 ′; R: 5 ′-AGCTACCAGGG

165

AACAAAGCC-3 ′; RT: 5 ′-GGTTTCCCTTTCGCTT
TCAAGT-3′). An MJ Research PTC-200 Thermocycler
(USA) was used for PCR reactions with the following
conditions: 1× Taq Buffer A (Fisher Bioreagents) with
a final concentration of 2.0 mmol/L MgCl2,
200 μmol/L dNTPs, 300 nmol/L of each primer and
1.25 U of Taq DNA Polymerase (Fisher Bioreagents).
Cycling conditions were 95 °C for 2 minutes,
followed by 35 cycles of 95 °C for 30 seconds, 56 °C
for 30 seconds and 72 °C for 60 seconds and a final
extension of 72 °C for 10 minutes. The resultant PCR
products were subjected to electrophoresis on 1%
agarose gel. Products generated from the F and R
primer pair were 627 bp in length and reflected a wild
type chromosome 14. Products from the F and RT
primer pair resulted in an 847 bp product, indicating
that the transgene was present.
Protein preparation
Protein extraction and sample preparation were
performed as described previously[21]. Protein was
extracted by homogenization of tissue samples in
radioimmunoprecipitation assay (RIPA) buffer
(1 mL/100 mg; 20 mmol/L Tris, 137 mmol/L NaCl,
10% glycerol, 1% NP40, 0.1% SDS, 0.5% deoxycholic
acid, 2 mmol/L EDTA, 1 mmol/L PMSF, 1% protease
inhibitor cocktail and 1% phosphatase inhibitor
cocktail) using a Biospec Tissue Tearor (USA).
Protein concentrations were quantified using a
bicinchoninic acid (BCA) assay (Pierce Biotechnology, USA) according to the manufacturer's
instructions. Extracted protein was mixed with 4×
loading dye (2% Tris [pH 6.8], 28% glycerol, 20%
SDS and Orange G) containing 100 mmol/L DTT and
frozen at −80 °C until immunoblotting.
Immunoblotting
Immunoblotting was performed as described
previously[21]. Tissue samples were segregated by
anatomical regions (brain, thoracic, digestive, renal
and reproductive) and protein (10 or 20 μg) was
separated using SDS-PAGE (15%) before transfer to
an Immobilon-FL polyvinylidene difluoride membrane
(Millipore, USA) pre-soaked in methanol. After electrophoretic transfer, nonspecific binding was blocked
by incubation of blots in Odyssey Blocking Buffer
(Cat. No. 927-40100; LI-COR Biosciences, USA) for
approximately 3 hours at room temperature. Membranes were then incubated with a mouse monoclonal
primary antibody directed against ZsGreen1 (1:1000;
Cat. No. 632598; Clontech), diluted in Odyssey
Blocking Buffer with 0.05% Tween-20 and shaken at
4 °C overnight. The following morning, membranes
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were rinsed in Tris-buffered saline with 0.05%
Tween-20 (TBS-T) prior to incubation with a goat
anti-mouse secondary antibody (1:15 000; IRDye 680;
Cat. No. 926-32220; LI-COR Biosciences) in Odyssey
Blocking Buffer plus 0.05% Tween-20 and 0.025%
SDS for 1 hour at room temperature. Blots were
rinsed with TBS-T to remove excess secondary
antibody and briefly rinsed in TBS to remove Tween20 prior to imaging.
Quantification of ZsGreen1 abundance
Blots were scanned on an Odyssey Infrared Imager
(700 channel; intensity 5.0; 169-micron resolution; LICOR Biosciences) and converted to greyscale for
analysis. Band density was quantitated with Odyssey
imaging software (version 2.1; LI-COR Biosciences)
which automatically subtracted background signal to
determine densitometry. Since the abundance of
common loading controls (e.g., β-actin) differed
across tissue types, total protein levels within each
lane were used as the loading control according to
Eaton et al[22]. After ZsGreen1 imaging, membranes
were stained with GelCode Blue Safe Protein Stain
(ThermoScientific, USA) for approximately 1 hour
and then rinsed with 50% methanol and 1% acetic
acid solution for 1 hour. Blots were reimaged (700
channel; intensity 1.0; 169-micron resolution; LI-COR
Biosciences), converted to greyscale and quantitated
using Odyssey imaging software to determine the
relative quantity of total protein present in each
sample. Data were presented as the relative band
density of ZsGreen1 normalized by the total protein
levels within the entire lane as described previously[21].
The negative control in this experiment was wild-type
porcine skin. During quantification, ZsGreen1 was
considered detectable when the relative band density
of the transgenic sample was greater than the nonspecific signal detected for the control, which
inherently lacked ZsGreen1. ZsGreen1 was considered
undetectable when values were less than or equal to
the relative band density of the control sample.
Statistical analysis
Analyses were performed using the Statistical
Analysis System (version 9.4, SAS Institute Inc.
USA). Analysis of variance (ANOVA) was performed
via the MIXED procedure of SAS with the original
model including tissue type, genotype (hemizygous or
homozygous) and their interaction as the fixed effects.
There was no effect of genotype or tissue type by
genotype interaction (P>0.05), so these effects were
removed from the statistical model; thus, homozygous
and hemizygous data were grouped together for the
final analysis. Litter was included in the model as a

random effect and P<0.05 was considered statistically
significant. Results were presented as least squares
means ± the standard error of the mean.

Results
Identification of hemizygous and homozygous
CMV-ZsGreen1 transgenic piglets
The presence of ZsGreen1 in the skin of neonatal
transgenic piglets was detected visually (Fig. 1A) and
via immunoblotting (Fig. 1B), indicative of CMV
promoter activity. Even without the UV light, transgenic animals were identifiable via the yellow hue of
their skin (data not shown). The genotype of the
animals was confirmed by conventional PCR (Fig. 1D);
a schematic depicting the genotyping method is
available (Fig. 1C). ZsGreen1 was not detected in the
skin of control piglets (Fig. 1A and B).
ZsGreen1 fluorescence within tissues of CMVZsGreen1 transgenic piglets
ZsGreen1 fluorescence was visually detectable
within internal organs of transgenic piglets under UV
light; fluorescence was absent in wild-type pig organs
(Fig. 2A; right panel). Fluorescence appeared robust
in the intestines (Fig. 2A; middle panel), cerebellum
(Fig. 2B; left panel), anterior pituitary gland (Fig. 2B;
middle panel) and heart (Fig. 2B; right panel), but
modest within the stomach (Fig. 2A; middle panel).
ZsGreen1 was not visually detectable in the cerebrum
(Fig. 2B; left panel), posterior pituitary gland (Fig.
2B; middle panel), liver or spleen (Fig. 2A; middle
panel). Differential fluorescent patterns were observed
within organs as well. In the brain, ZsGreen1
fluorescence was intense within the cerebellum but
not visually apparent in the cerebrum (Fig. 2B; left
panel). In addition, the highest expression of ZsGreen1
appeared in the right ventricle compared with the
other regions of the heart (Fig. 2B; right panel).
Quantification of ZsGreen1 in transgenic porcine
tissues
Neural and endocrine tissues of the brain
Quantification of relative band density indicated
that ZsGreen1 was present in 5 of the 6 tissues
examined but only undetectable within the
hypothalamus (Fig. 3A). There was an effect of tissue
type on ZsGreen1 protein levels within the brain and
the nervous system (P<0.0001; Fig. 3A). The
abundance of ZsGreen1 was the greatest in the
anterior pituitary gland, intermediate in the cerebellum
and lowest in the cerebrum, spinal cord and posterior
pituitary gland (P<0.05), which were not different
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Fig. 1 Production of CMV-ZsGreen1 in hemizygous and homozygous transgenic piglets. A: Representative photograph of control
piglet (left) with homozygous (middle) and hemizygous (right) transgenic siblings. ZsGreen1 was visualized with an ultraviolet light and a
Roscolux #15 filter. B: Representative immunoblot of ZsGreen1 in the skin of control piglets (n=3) as well as hemizygous (n=3) and
homozygous (n=3) transgenic littermates. Lower panel represents total protein levels within each lane. C: Schematic demonstrating the
genotyping method to distinguish among control, homozygous and hemizygous piglets. Detection of monoallelic or biallelic transgene
integration was performed by conventional PCR using 3 primers. The forward primer, denoted by the black arrow, amplifies a non-coding
region upstream of the transgene integration site. A reverse primer (grey arrow) aligns a non-coding region downstream of the transgene and
a second reverse primer (indicated in green), detects the transgene. If a transgene is present, the resulting PCR product will be 847 bp;
however, in the absence of the transgene, the PCR product will be 627 bp. D: PCR detection of transgene integration and copy number. The
presence of only an 847 bp PCR product indicates a homozygous transgenic animal whereas a 627 bp product indicates a control animal. If
both 847 and 627 bp products are detected, the genotype is hemizygous transgenic.

from each other (P>0.05; Fig. 3A).
Thoracic tissues
ZsGreen1 was detected by immunoblotting in all 9
thoracic tissues evaluated. An effect of tissue type was
observed among the thoracic organs of CMV-ZsGreen1
piglets (P<0.0001; Fig. 3B). The right ventricle and
skeletal muscle both produced more ZsGreen1 than
the other tissues within the thoracic region (P<0.05),
but did not differ from one another (P>0.05; Fig. 3B).
Levels of ZsGreen1 in the thyroid, right atrium, left
atrium, left ventricle, lung, thymus and lymph node
were similar to each other (P>0.05; Fig. 3B).
Digestive tissues
ZsGreen1 was detected in all 11 digestive organs
examined, but protein levels differed among tissue

types (P<0.0001; Fig. 4). The ZsGreen1 level in the
salivary gland was greater than those in the esophagus,
stomach, pancreas, duodenum, jejunum, ileum, spleen,
large intestine, gall bladder and liver (P<0.05; Fig. 4).
Specifically, ZsGreen1 was 75-fold more abundant in
the salivary gland compared to the pancreas. The
protein amounts in the esophagus were higher than
those in the pancreas, ileum, spleen, gall bladder and
liver (P<0.05), but not within the stomach, duodenum,
jejunum and large intestine (P>0.05; Fig. 4). ZsGreen1
levels in the other tissues (stomach, pancreas,
duodenum, jejunum, ileum, spleen, large intestine,
gall bladder and liver) were similar to each other
(P>0.05; Fig. 4).
Renal and reproductive tissues
An effect of tissue type was observed among renal
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Fig. 2 Visualization of ZsGreen1 fluorescence within internal organs of transgenic piglets. A: Representative image of ZsGreen1
fluorescence in the internal organs of control and transgenic piglets. The left panel represents internal organs from a transgenic piglet. The
middle panel represents a fluorescent image of internal organs from a transgenic piglet; and the right panel is a UV image of wild-type piglet
organs. B: Representative fluorescent images of a transgenic piglet brain (left panel), anterior and posterior pituitary glands (within the sella
turcica of the skull; middle panel) and heart (right panel). Anterior pituitary gland and posterior pituitary gland are indicated by white and
grey arrows, respectively. ZsGreen1 expression was abundant within the right ventricle of the heart (right panel). ZsGreen1 fluorescence was
detected with UV light and a Roscolux #15 filter. L: liver; St: stomach; Sp: spleen; I: intestines; Cr: cerebrum; Cl: cerebellum; AP: anterior
pituitary; PP: posterior pituitary; RA: right atrium; RV: right ventricle; LA: left atrium; LV: left ventricle.

tissues that were screened (P=0.0001), with 4 out of
5 tissues expressing ZsGreen1. We were unable to
detect ZsGreen1 within the kidney cortex (Fig. 5A).
The medulla region of the adrenal gland produced
more ZsGreen1 than the adrenal cortex, kidney
medulla and bladder (P<0.05; Fig. 5A). Abundance of
ZsGreen1 was higher in the adrenal cortex than the
kidney medulla (P<0.05), whereas the level in the
bladder was similar to that in both tissues (P>0.05;
Fig. 5A). Within female reproductive tissues, we
detected ZsGreen1 protein in the ovary and uterus, albeit at reduced levels, but not in the oviduct (Fig. 5B).
However, no differences in ZsGreen1 abundance were
detected between the ovary and uterus of female
transgenic piglets (P=0.4016; Fig. 5B).

Discussion
In accord with the ubiquitous nature of the CMV
promoter, ZsGreen1 protein was detected in all
porcine tissues examined, except in the hypothalamus,
kidney cortex and oviduct. Our results, however,
demonstrated variable levels of CMV promoter
activity across organs of the neonatal piglet. Other
researchers observed similar results in animals

expressing a transgene driven by the CMV promoter[11,17–18,23]. Several hypotheses regarding the
differential activity of the CMV promoter in vivo have
arisen. The activity of the CMV promoter within a
given cell type may be influenced by integration
site[24]; namely, activation may only occur in
transcriptionally active regions of the genome[10].
Stochastic silencing can happen when a transgene is
integrated near a heterochromatic region, such as a
centromere[24], or when multiple copies of the
transgene integrate in tandem[25], due to local formation of heterochromatin[26]. Promoter suppression
could also be caused by methylation, which can
silence transgenes in vitro and in vivo[12–14]. Furth et
al[23] observed marked differences in CMV promoter
activity across tissues in two transgenic mouse lines
harboring the same transgene. Conversely, Vasey et
al[18] detected a similar CMV promoter activity profile
in pigs and chickens harboring the same transgene, albeit integrated in different chromosomal regions[18–19].
The activity patterns were also similar in multiple
transgenic chicken lines expressing different reporter
genes directed by the CMV promoter[17]. Like Vasey
et al[18], we observed widespread CMV activity
throughout CMV-ZsGreen1 pigs with robust activity
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Fig. 3 Protein levels of ZsGreen1 within brain and thoracic tissues of CMV-ZsGreen1 piglets. A: Representative immunoblot of neural
and endocrine tissues from CMV-ZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (the upper panel). The
middle panel represents total protein levels serving as the loading control. Quantification of immunoblots revealed differences in relative
ZsGreen1 protein levels between tissue types (P<0.0001; the lower panel). B: Representative immunoblot of the thoracic tissue from CMVZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (the upper panel). The middle panel represents total protein
levels serving as the loading control. Quantification of immunoblots revealed differences in relative ZsGreen1 protein levels between tissue
types (P<0.0001; the lower panel). Bars in a, b, c, with alternate letters differ (P<0.05). ND: not detected.

in the skin and salivary glands, despite different
integration sites and transgenes.
In addition to chromatin status, the repertoire of
transcription factors within the cell dictate CMV
promoter activity[10]. Mella-Alvarado et al hypothesized that CMV promoter activity was robust in the
cells that were most voraciously infected by CMV and
reflective of optimal transcription factor expression[11].
Numerous transcription factors have been implicated
in the regulation of the CMV promoter, including
nuclear factor kappa-light-chain-enhancer of activated
B cells[10,18,27], yin yang 1[10], activator protein 1 and
its major subunits (c-Fos and c-Jun)[27], p53,
cAMP response element-binding protein/activating
transcription factor, retinoic acid receptor[28],

specificity protein 1[9], nuclear factor I, serum
response factor, Elk-1 and CCAAT/enhancer-binding
protein[29]. While we detected different ZsGreen1
protein levels between the cortex and medulla within
the kidney and adrenal glands, we were unable to
comprehensively evaluate the CMV-ZsGreen1
reporter among different cell types in this initial study.
Consistent with elevated CMV promoter activity in
exocrine glands, as previously noted in CMV-GFP
pigs[18], ZsGreen1 protein levels were increased in the
salivary glands of transgenic piglets. In the pancreas,
however, we failed to detect elevated ZsGreen1 levels,
conflicting with other reports about increased CMV
promoter activity within the porcine pancreas[18–19].
This discrepancy could be related to age-specific
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Fig. 4 Protein levels of ZsGreen1 within digestive tissues of CMV-ZsGreen1 piglets. Representative immunoblot of digestive tissues
from CMV-ZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (the upper panel). The middle panel represents
total protein levels serving as the loading control. Quantification of immunoblots revealed differences in relative ZsGreen1 protein levels
between tissue types (P<0.0001; the lower panel). Bars in a, b, c, with alternate letters differ (P<0.05).

activity levels of the CMV promoter, as noted in
zebrafish[11]. In our study, neonatal (1 day of age)
piglets were utilized, whereas others examined CMV
promoter activity in the pancreases of older (2 months
to 1 year of age) pigs[18–19]. Likewise, we detected
robust ZsGreen1 abundance in the pancreases of 1month old piglets (unpublished data). Interestingly,
the pancreas is largely quiescent in the neonatal piglet;
the production of pancreatic juices and enzymes
increase dramatically after weaning[30]. In the liver, we
also detected little CMV promoter activity. Others
reported similar levels of CMV promoter activity in
porcine hepatocytes[18] and chicken liver[17], although,
GFP was robustly driven by the CMV promoter in
hepatocytes of zebrafish[11]. Thus, the CMV promoter
is not uniformly effective in all exocrine organs and
its activity varies across species.
Based on our visual observation of ZsGreen1

production in the skin of hemizygous and homozygous piglets (Fig. 1A), we hypothesized that an
additional transgene would yield more ZsGreen1
protein in the organs of homozygous animals.
However, no genotype effect was detected based upon
quantification of immunoblots for ZsGreen1. These
results may be due to monoallelic expression, which
has been described in other transgenic animal
models[25,31]. Conversely, translation of ZsGreen1
transcripts may be impaired in homozygous animals.
Post-transcriptional silencing of high expressing
transgenes is common in homozygous (but not
hemizygous) plants and may be mediated by short
interfering RNA[32]. Doubling transgene transcription
may yield copious mRNA transcripts, breaching a
threshold that triggers cellular processes to suppress
transgene translation[33]. Nonetheless, transgene copy
number did not significantly affect the production of
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Fig. 5 Protein levels of ZsGreen1 within renal and reproductive tissues of CMV-ZsGreen1 piglets. A: Representative immunoblot of
the renal tissue from CMV-ZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (the upper panel). The middle
panel represents total protein levels serving as the loading control. Quantification of immunoblots revealed differences in relative ZsGreen1
protein levels between tissue types (P=0.0001; the lower panel). B: Representative immunoblot of the reproductive tissue from CMVZsGreen1 transgenic piglets (n=6) using an antibody directed against ZsGreen1 (upper panel). The middle panel represents total protein
levels serving as the loading control. Quantification of immunoblots indicated that there were no differences in relative ZsGreen1 abundance
between tissue types (P=0.4016; the lower panel). Bars in a, b, c, with alternate letters differ (P<0.05). ND: not detected.

ZsGreen1 protein in this study.
Notably, this ZsGreen1 swine model is well suited
for re-engineering the transgene locus since expression
of the transgene is readily detectable, the transgene is
present in a single copy and the integration site has
been identified[2]. This swine line could be used to test
somatic cell gene editing using CRISPR/Cas9 systems
or base editor nucleases by targeting the ZsGreen1
transgene sequence. In addition, the model is a useful
tool for testing germline genome editing approaches in
vivo such as Genome editing via Oviductal Nucleic
Acids Delivery[34]. Finally, re-engineering the
transgenic CMV-ZsGreen1 locus of this pig model
can make it suitable for other applications. The

ZsGreen1 coding sequence can be disrupted to create
a frameshift mutation in ZsGreen1, creating a model
as a reporter for homology directed repair studies.
Alternatively, a floxed red fluorescent protein could
be inserted upstream of the ZsGreen1 cassette to serve
as a Cre recombinase reporter. Re-engineering of the
locus can be achieved via Easi-CRISPR, a highly
efficient genome engineering method[35].
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